minalrestat has been researched along with Galactosemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hohman, TC; Malamas, MS; Millen, J | 1 |
| Akamine, EH; Carvalho, MH; de Cássia Tostes, R; Fortes, ZB; Hohman, TC; Nigro, D | 1 |
2 other study(ies) available for minalrestat and Galactosemias
| Article | Year |
|---|---|
Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Cattle; Diabetes Mellitus, Experimental; Dogs; Drug Evaluation, Preclinical; Erythrocytes; Galactitol; Galactosemias; Glyceraldehyde; In Vitro Techniques; Isoquinolines; Lens, Crystalline; Male; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spiro Compounds; Stereoisomerism | 1994 |
Minalrestat, an aldose reductase inhibitor, corrects the impaired microvascular reactivity in diabetes.
Topics: Aldehyde Reductase; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Interactions; Galactosemias; Imides; Male; Quinolones; Rats; Rats, Wistar; Splanchnic Circulation; Vasoconstrictor Agents | 2003 |